Once-daily monotherapy with elagolix significantly reduced heavy menstrual bleeding in women with uterine leiomyomas compared to a placebo, based on data from 82 individuals. Uterine leiomyomas are common in premenopausal women, and 60% experience heavy menstrual bleeding, but nonsurgical options as an alternative to hysterectomy are limited, wrote Eric Brown, MD, of Gyn-Care, Atlanta, Georgia,...